Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kooijman, Elke ^a   Nijboer, Cora H ^a   Van Velthoven, Cindy T J ^a   Mol, Wouter ^b   Dijkhuizen, Rick M ^b   Kesecioglu, Jozef ^a   Heijnen, Cobi J ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; PROTEIN CINC 1; PROTEIN IBA 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; GENE EXPRESSION; GRAY MATTER; MALE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROGNOSIS; RAT; SENSORIMOTOR FUNCTION; SUBARACHNOID HEMORRHAGE; WHITE MATTER;

EID: 84897416974     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090584     Document Type: Article

References (51)

1. The ACROSS group (2000) Epidemiology of Aneurysmal Subarachnoid Hemorrhage in Australia and New Zealand: Incidence and Case Fatality From the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 31: 1843-1850.
2. van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid haemorrhage. Lancet 369: 306-318. (Pubitemid 46136491)
3. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, et al. (2005) Defining vasospasm after Subarachnoid hemorrhage in rats. Acta Neurochir Suppl 95: 377-380.
4. Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA (2010) A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg 73: 654-667.
5. Silasi G, Colbourne F (2009) Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res 198: 380-387.
6. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, et al. (2008) Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: New perspectives. Exp Neurol 213: 336-344.
7. Kimball MM, Velat GJ, Hoh BL (2011) Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care 15: 336-341.
8. Koenig MA (2012) Management of delayed cerebral ischemia after subarachnoid hemorrhage. Continuum (Minneap Minn) 18: 579-597.
9. Iseda K, Ono S, Onoda K, Satoh M, Manabe H, et al. (2007) Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. Jô Neurosurg 107: 128-35. (Pubitemid 47026480)
10. Prunell GF, Svendgaard NS, Alkass K, Mathiesen T (2005) Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery 56: 1082-1092.
11. Cahill J, Calvert JW, Zhang JH (2006) Mechanisms of early brain injury after subarachnoid hemorrhage. Jô Cereb Blood Flow Metab 26: 1341-1353.
12. Chen G, Li Q, Feng D, Hu T, Fang Q, et al. (2013) Expression of NR2B in different brain regions and effect of NR2B antagonism on learning deficits after experimental subarachnoid hemorrhage. Neuroscience 231: 136-144.
13. Wang Z, Hu T, Feng D, Cheng G (2013) Expression of synaptic cell adhesion moelcule 1 (SynCAM 1) in different brain regions in a rat subarachnoid hemorrhage model. Neurol Sci 34: 1331-1338.
14. Khalili MA, Anvari M, Hekmati-Moghadam SH, Sadeghian-Nodoushan F, Fesahat F, et al. (2012) Therapeutic benefit of intravenous transplantation of mesenchymal stem cells after experimental subarachnoid hemorrhage. Jô Stroke Cerebrovasc Dis 21: 445-451.
15. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA (2003) Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 52: 165-175.
16. Nijboer CH, Kavelaars A, Vroon A, Groenendaal F, van Bel F, et al. (2008) Low endogenous G-protein-coupled receptor kinase 2 sensitizes the immature brain to hypoxia-ischemia-induced gray and white matter damage. Jô Neurosci 28: 3324-3332. (Pubitemid 351469332)
17. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, et al. (2007) Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. Jô Cereb Blood Flow Metab 27: 282-292. (Pubitemid 46148455)
18. Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. Jô Neurosci Methods 167: 327-334. (Pubitemid 350235625)
19. Willemen HL, Eijkelkamp N, Wang H, Dantzer R, Dorn GW, et al. (2010) Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain 150: 550-560.
20. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. Jô Neurosci Methods 53: 55-63. (Pubitemid 24238751)
21. Sozen T, Tsuchimyama R, Hasegawa Y, Suzuki H, Jadhav V, et al. (2009) Role of interleukin-1 b in early brain injury after subarachnoid hemorrhage in mice. Stroke 40: 2519-2525.
22. Hendryk S, Jarzab B, Josko J (2004) Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 25: 141-147. (Pubitemid 44783371)
23. Mathiesen T, Edner G, Ulfarsson E, Andersson B (1997) Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor α following subarachnoid hemorrhage. Jô Neurosurgery 87: 215-220. (Pubitemid 27349105)
24. Chou SH, Feske SK, Atheron J, Konigsberg RG, De Jager PL, et al. (2012) Early elevation of serum tumor necrosis factor-alpha is associated with poor outcome in subarachnoid hemorrhage. Jô Investig Med 60: 1054-1058.
25. Dziurdzik P, Krawczyk L, Jalowiecki P, Kondera-Anasz Z, Menon L (2004) Serum interleukin-10 in ICU patients with severe acute central nervous system injuries. Inflamm Res 53: 338-3343.
26. Kubota T, Handa Y, Tsuchida A, Kaneko M, Kobayashi H, et al. (1993) The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke 24: 1993-2000.
27. Semple BD, Kossmann T, Morganti-Kossmann MC (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/ CXCR2 networks. Jô Cereb Blood Flow Metab 30: 459-473.
28. Tiebosch I, Dijkhuizen R, Cobelens P, Bouts M, Zwartbol R, et al. (2013) Effect of Interferon-β on Neuroinflammation, Brain Injury and Neurological Outcome After Experimental Subarachnoid Hemorrhage. Neurocrit Care 18: 96-105.
29. Lu H, Shi JX, Chen HL, Hang CH, Wang HD, et al. (2009) Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage. Brain Res 1262: 73-80.
30. Schneider T, Issekutz AC (1996) Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. Jô Immunol Methods 198: 1-14. (Pubitemid 26348913)
31. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. Jô Leukoc Biol 77: 598-625.
32. van der Veen BS, de Winther MP, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11: 2899-2937.
33. Malle E, Furtmuller PG, Sattler W, Obinger C (2007) Myeloperoxidase: a target for new drug development? Brô Jô Pharmacol 152: 838-854. (Pubitemid 350100486)
34. Kato H, Kawaguchi M, Inoue S, Hirai K, Furuya H (2009) The Effects of β- Adrenoceptor Antagonists on Proinflammatory Cytokine Concentrations After Subarachnoid Hemorrhage in Rats. Anesth Analg 108: 288-295.
35. Lad SP, Hegen H, Gupta G, Deisenhammer F, Steinberg GK (2012) Proteomic Biomarker Discovery in Cerebrospinal Fluid for Cerebral Vasospasm Following Subarachnoid Hemorrhage. Journal of Stroke and Cerebrovascular Diseases 21: 30-41.
36. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, et al. (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. Jô Cereb Blood Flow Metab 29: 317-330.
37. Rothwell NJ (1999) Cytokines-killers in the brain? The Journal of Physiology 514: 3-17.
38. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, et al. (2001) Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. Jô Cereb Blood Flow Metab 21: 157-62. (Pubitemid 32143977)
39. Takizawa T, Tada T, Kitazawa K, Tanaka Y, Hongo K, et al. (2001) Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res 23: 724-730. (Pubitemid 32952702)
40. Dietmann A, Lackner P, Fisher M, Broessner G, Pfausler B, et al. (2012) Soluble endoglin and transforming growth factor-β and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study. Cerebrovasc Dis 33: 16-22.
41. Aihara Y, Kasuya H, Onda H, Hori T, Takeda J (2001) Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32: 212-217. (Pubitemid 32063848)
42. Wu X, Lu Y, Dong Y, Zhang G, Zhang Y, et al. (2012) The inhalation anesthetic isoflurane increases levels of proinflammatory TNFα, IL-6, and IL-1β. Neurobiol Aging 33: 1364-1378.
43. Franklin RJM, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9: 839-855.
44. Segovia KN, McClure M, Moravec M, Luo NL, Wan Y, et al. (2008) Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 63: 520-530. (Pubitemid 351614718)
45. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T (2005) Delayed cell death related to acute cerebral blood flow changes following subarachnoid hemorrhage in the rat brain. Jô Neurosurg 102: 1046-1054. (Pubitemid 43193974)
46. Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH (2010) Mechanisms of Osteopontin-Induced Stabilization of Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Rats. Stroke 41: 1783-1790.
47. Bessis A, Bechade C, Bernard D, Roumier A (2007) Microglial control of neuronal death and synaptic properties. Glia 55: 233-238. (Pubitemid 46225955)
48. Fleiss B, Gressens P (2012) Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 11: 556-566.
49. Jeon H, Ai J, Sabri M, Tariq A, Macdonald RL (2010) Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience 169: 1805-1814.
50. Ostrowski RP, Colohan AR, Zhang JH (2006) Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28: 399-414. (Pubitemid 43967787)
51. Sherchan P, Lekic T, Suzuki H, Hasegawa Y, Rolland W, et al. (2011) Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular-induced subarachnoid hemorrhage in rats. Jô Neurotrauma 28: 2503-2512.